https://science.xyz/news/primavera-trial-preliminary-results/
"Science Corporation, a leader in brain-computer interface (“BCI”) technology,
has announced the preliminary clinical trials results for its PRIMA retinal
implant. The patients in the trials had lost their central visual field, which
makes them unable to read and struggle to recognize faces. The results showed
that the PRIMA implant restored real form vision in these patients such that
sequences of letters can be read with a clinically meaningful improvement of
letter acuity.
”The results demonstrate a milestone in the treatment of blindness caused by
geographic atrophy due to age-related macular degeneration. For the first time
it was possible to restore real form vision in a retina that has deteriorated
due to age-related macular degeneration” said Professor Frank Holz, MD (PDF),
scientific coordinator of the PRIMAvera study. “Prior to this, there have been
no real treatment options for these patients,” continued Professor Holz, who is
Chairman and Professor, Department of Ophthalmology, at the University of Bonn,
Germany.
Max Hodak, Science Corp CEO, added: “To my knowledge, this is the first time
that restoration of the ability to fluently read has ever been definitively
shown in blind patients. This represents an enormous turning point for the
field, and we’re incredibly excited to bring this important technology to
market over the next few years.”
The study was designed to demonstrate PRIMA’s safety and efficacy to reach
European market approval (CE mark). PRIMA, owned and manufactured by Science
Corp, is based on original research done at Stanford University and later by
Pixium Vision of France."
Via
What Could Go Right? The Election News You Aren’t Reading:
https://theprogressnetwork.org/extremist-group-activity-2024-election/
Cheers,
*** Xanni ***
--
mailto:xanni@xanadu.net Andrew Pam
http://xanadu.com.au/ Chief Scientist, Xanadu
https://glasswings.com.au/ Partner, Glass Wings
https://sericyb.com.au/ Manager, Serious Cybernetics
